The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial results from EXCEED, a phase 1 study of LY4101174, an antibody-drug conjugate targeting Nectin-4, in participants with advanced or metastatic urothelial carcinoma.
 
Xin Gao
Honoraria - OncLive
Consulting or Advisory Role - 858 Therapeutics; Abeona Therapeutics; ADC Therapeutics; Dendreon; Flare Therapeutics; Hinova Pharmaceuticals; Janssen; Kanaph Therapeutics; Loxo/Lilly
Research Funding - Acerand Therapeutics (Inst); ALX Oncology (Inst); Aprea Therapeutics (Inst); Aravive (Inst); Arvinas (Inst); Bayer (Inst); Exelixis (Inst); Halda Therapeutics (Inst); Harpoon therapeutics (Inst); Janux Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); Poseida therapeutics (Inst); Regeneron (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst)
 
Rafael Morales-Barrera
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Merck/Pfizer; MSD
Speakers' Bureau - Astellas Pharma; Merck/Pfizer; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Merck; MSD; Pfizer; Roche/Genentech
 
Tian Zhang
Leadership - Archimmune Therapeutics (I); Capio BioSciences (I)
Stock and Other Ownership Interests - Archimmune Therapeutics (I); Capio Biosciences (I); Nanorobotics (I)
Honoraria - Aptitude Health; Clinical Care Options; Curio Science; Dava Oncology; Mashup Media; MJH Life Sciences; Peerview
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Dendreon; Eisai; EMD Serono; Exelixis; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Xencor
Research Funding - ALX Oncology (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Janux Therapeutics (Inst); Kura Oncology (Inst); Loxo/Lilly (Inst); Merck (Inst); OncoC4; Pfizer (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Bayer; Janux Therapeutics; Johnson & Johnson/Janssen
Other Relationship - ASCO; Kidney Cancer Association; KidneyCan; Myrovlytis Trust; Winn Foundation
 
Melissa Reimers
Consulting or Advisory Role - Astellas Pharma; Cicadea Biotech; Eisai; EMD Serono; Lilly; Loxo; Pathos AI, Inc
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca (Inst); BMS GmbH & Co. KG (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); FORMA Therapeutics (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); ProfoundBio (Inst)
 
Jacqueline Brown
Honoraria - Curio Science; DAVA Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; EMD Serono; Exelixis; Pfizer; Xencor
Research Funding - Duality Biologics; Hookipa Pharma (Inst); Loxo/Lilly (Inst); Macrogenics; Medicenna (Inst); Merck (Inst); Novartis (Inst); Pliant; Surface Oncology (Inst); Xencor (Inst)
 
Armelle Vinceneux
Consulting or Advisory Role - AAA/Endocyte/Novartis; Ipsen; Loxo/Lilly; Pfizer
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Eisai; Johnson & Johnson/Janssen; MSD Oncology; Pfizer
 
Daniel Castellano Gauna
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Novartis; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - GUARD cosortium. President Executive board
 
Amita Patnaik
Honoraria - Texas Society of Clinical Oncology (TxSCO)
Consulting or Advisory Role - Bayer; Biotheyx; Bristol-Myers Squibb (I); Daiichi Sankyo, Inc.; Genentech/Roche (I); Gilead Sciences; HalioDx; Ionova; Janssen; Loxo; Merck; MERCK (I); Novartis; Pfizer; Pfizer; Quanta Therapeutics; Scorpion Therapeutics; Seagen; Silverback Therapeutics
Speakers' Bureau - Merck; San Antonio Pancreatic Cancer Symposium
Research Funding - 1200 Pharma (Inst); AADi (Inst); Abbvie (Inst); Alpine Immune Sciences (Inst); Ambrx (Inst); Amgen (Inst); Arcus Biosciences (Inst); Arcus Ventures (Inst); Arvinas (Inst); Astellas Pharma (Inst); BioNTech (Inst); BioTheryX (Inst); Bolt Biotherapeutics (Inst); Carrick Therapeutics (Inst); Compugen (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Daiichi-Sankyo (Inst); Ensem (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Fochon Pharmaceuticals (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); IGM Biosciences (Inst); Infinity Pharmaceuticals (Inst); Institut de Recherches Internationales Servier (I.R.I.S) (Inst); Ionova (Inst); Ionova (Inst); Klus Pharma (Inst); KSQ Therapeutics (Inst); Lilly (Inst); Livzon (Inst); Loxo (Inst); Loxo@Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); MOMA Therapeutics (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Olema Oncology (Inst); Ottimo (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Pionyr (Inst); Plexxikon (Inst); Prelude Therapeutics (Inst); Pyrotec Therapeutics (Inst); Quanta Therapeutics (Inst); Roche (Inst); Sanofi (Inst); Scorpion Therapeutics (Inst); Seagen (Inst); Seagen (Inst); SERVIER (Inst); Surface Oncology (Inst); Symphogen (Inst); Syndax (Inst); Tesaro (Inst); Upsher-Smith (Inst); Vigeo Therapeutics (Inst); Vividion Therapeutics (Inst)
 
Nobuaki Matsubara
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Janssen; Lilly; Pfizer; Sanofi; Seagen
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer Yakuhin (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Eisai (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst)
 
Loic Lebellec
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Deciphera; Eisai Europe
 
Philippe Barthelemy
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Kristen Spencer
Employment - NYU School of Medicine
Honoraria - Amplity Health; AstraZeneca; Bio Ascend Oncology; Dava Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Caris Life Sciences; Exelixis; Genentech/Roche
Research Funding - BMS Foundation
 
Nuria Kotecki
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Alejandro Falcon Gonzalez
Consulting or Advisory Role - AstraZeneca; Menarini Group; MSD; Pfizer; Roche/Genentech; Steve
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Dr. Reddy's Laboratories; Eisai; Gilead Sciences; Grunenthal; Lilly; Novartis; Pfizer; Roche/Genentech; Seagen
 
Craig Gedye
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Icon Cancer Care; Merck Sharp & Dohme (Inst); Novotech; SERVIER (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
Kazuki Sudo
Honoraria - AstraZeneca; Eisai; Janssen; MSD; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - MSD; Pfizer
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Loxo/Lilly; Merck; MSD; Pfizer; PRA Health Sciences; Takeda
 
Hongmei Han
Employment - Lilly
Stock and Other Ownership Interests - Lilly; Pfizer; Revolution Medicines
 
Kaity Aptaker
Employment - Lilly
 
Traci Kelly
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Jonathan Rosenberg
Honoraria - Astellas Pharma; Merck
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Domain Therapeutics; EMD Serono; Generate Biomedicines; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Samsung Bioepis; Seagen; Summit Therapeutics; Tyra Biosciences
Research Funding - Acrivon Therapeutics; Astellas Pharma (Inst); Bristol-Myers Squibb; Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - Amplification of chromosome 1q23 to predict cancer outcomes (Inst); Predictor of platinum sensitivity (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
(OPTIONAL) Uncompensated Relationships - Alliance for Clinical Trials in Oncology; Kalivir Immunotherapeutics